Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Structure Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:GPCR | Benzinga

Q: What sector and industry does Structure Therapeutics (GPCR) operate in?

Structure Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Explore Structure Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for GPCR.

Open	$23.50
Close	$23.74
Volume / Avg.	731.80K / 953.76K
Day Range	$23.20 - $24.19
52 Wk Range	13.22 - 62.74
Market Cap	$1.36B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	66
Short Interest	14.3%
Days to Cover	10.53

Recent News

uniQure, Hertz Global, Eli Lilly And Other Big Stocks Moving Higher On Thursday

Avi Kapoor

What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?

Pfizer ends danuglipron development after liver safety issue, boosting shares of Viking, Eli Lilly, and Novo Nordisk amid obesity drug competition.

Vandana Singh

AI Pharma: 2 Paths to AI-Powered Drug Investment

MarketBeat

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Dec 24

Jan

Feb

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$23.50
Close	$23.74
Volume / Avg.	731.80K / 953.76K
Day Range	$23.20 - $24.19
52 Wk Range	13.22 - 62.74
Market Cap	$1.36B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	66
Short Interest	14.3%
Days to Cover	10.53

About Structure Therapeutics Inc

Sector

Health Care

Industry

Pharmaceuticals

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small...

Got Questions? Ask

What is GPCR's current price trend?

What is GPCR's current ratio?

What is GPCR's gross margin?

What is GPCR's operating cash flow?

What’s driving GPCR's recent performance?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Structure Therapeutics (GPCR) stock?

You can purchase shares of Structure Therapeutics (NASDAQ:GPCR) through any online brokerage.

View our list of the best stock brokerages

Who are Structure Therapeutics (GPCR) competitors?

Other companies in Structure Therapeutics’s space includes: Supernus Pharmaceuticals (NASDAQ:SUPN), WAVE Life Sciences (NASDAQ:WVE), Tarsus Pharmaceuticals (NASDAQ:TARS), Phibro Animal Health (NASDAQ:PAHC) and ANI Pharmaceuticals (NASDAQ:ANIP).

What is the forecast, or price target, for Structure Therapeutics (GPCR) stock?

Structure Therapeutics has a consensus price target of $76.50.

What is the current price for Structure Therapeutics (GPCR)?

The stock price for Structure Therapeutics (NASDAQ: GPCR) is $23.74 last updated April 25, 2025 at 4:34 PM EDT.

Does Structure Therapeutics (GPCR) pay a dividend?

There are no upcoming dividends for Structure Therapeutics.

When is Structure Therapeutics (NASDAQ:GPCR) reporting earnings?

Structure Therapeutics’s Q1 earnings are confirmed for Thursday, May 8, 2025.

Is Structure Therapeutics (GPCR) going to split?

There is no upcoming split for Structure Therapeutics.

What sector and industry does Structure Therapeutics (GPCR) operate in?

Structure Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Comments

Structure Therapeutics Stock Price, Quotes and Forecasts

Structure Therapeutics (GPCR) Forecast